Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fractyl Health, Inc. (GUTS : NSDQ)

• Company Description    Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA. Number of Employees: 107

• Price / Volume Information    Yesterday's Closing Price: $1.52 Daily Weekly Monthly 20 Day Moving Average: 766,106 shares Shares Outstanding: 48.98 (millions) Market Capitalization: $74.44 (millions) Beta: 1.58 52 Week High: $4.92 52 Week Low: $0.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -29.95% -32.58% 12 Week 24.59% 4.80% Year To Date -26.21% -30.90%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3 VAN DE GRAAFF DRIVE SUITE 200 - BURLINGTON,MA 01803 USA ph: 781-902-8800 fax: - ir@fractyl.com http://www.fractyl.com

• General Corporate Information    Officers Harith Rajagopalan - Co-Founder; Chief Executive Officer and Director Lisa A. Davidson - Chief Financial Officer and Treasurer Kelly Barnes - Director William W. Bradley - Director Samuel Conaway - Director Peer Information Fractyl Health, Inc. (GSAC) Fractyl Health, Inc. (CASI) Fractyl Health, Inc. (ALCD.) Fractyl Health, Inc. (OMNN) Fractyl Health, Inc. (CGPI.) Fractyl Health, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 35168W103 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 48.98 Most Recent Split Date: (:1) Beta: 1.58 Market Capitalization: $74.44 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.39 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.51 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 11.68 Price/Cash Flow: - Price / Sales: 800.48 EPS Growth vs. Year Ago Period: 34.67% vs. Previous Quarter: 5.77% Sales Growth vs. Year Ago Period: -57.14% vs. Previous Quarter: -78.57% ROE 06/30/25 - - 03/31/25 - -228.66 12/31/24 - -146.91 ROA 06/30/25 - - 03/31/25 - -76.74 12/31/24 - -63.00 Current Ratio 06/30/25 - - 03/31/25 - 2.50 12/31/24 - 3.63 Quick Ratio 06/30/25 - - 03/31/25 - 2.50 12/31/24 - 3.63 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -92,286.02 Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -73,864.52 Pre-Tax Margin 06/30/25 - - 03/31/25 - -148,511.67 12/31/24 - -73,864.52 Book Value 06/30/25 - - 03/31/25 - 0.13 12/31/24 - 0.59 Inventory Turnover 06/30/25 - - 03/31/25 - 0.59 12/31/24 - 0.71 Debt-to-Equity 06/30/25 - - 03/31/25 - 4.61 12/31/24 - 1.06 Debt-to-Capital 06/30/25 - - 03/31/25 - 82.17 12/31/24 - 51.48

Powered by Zacks Investment Research ©